ARGENX SE (ARGX) is a biological products, (no diagnostic substances) company incorporated in Netherlands, listed on the Nasdaq. With a market capitalization of $46.8 billion, ARGENX SE is a large-cap company. The stock currently trades at $756.76, down 1.32% today, with a 52-week range of $510.06–$934.62. The company trades at a trailing P/E of 32.4x and a forward P/E of 22.2x.
No 10-K filings found.